Table 1 Patient and tumor characteristics by blood transfusion status before and after matching
Factors | All patients | P value | Matched patients | P value | ||
|---|---|---|---|---|---|---|
Non-transfused | Transfused | Non-transfused | Transfused | |||
Total n | 576 (90.6%) | 60 (9.4%) | 90 | 45 | ||
Age (SD) | 65.16 (10.54) | 66.21 (9.46) | 0.91 | 65.08 (10.8) | 65.8 (10.12) | 0.73 |
BMI (SD) | 27.06 (5.31) | 26.88 (7.33) | 0.15 | 27.37 (5.76) | 27.02 (7.59) | 0.79 |
Gender | 0.43 | 0.80 | ||||
Female | 267 (89.6%) | 31 (10.4%) | 48 (67.6%) | 23 (32.4%) | ||
Male | 309 (91.4%) | 29 (8.6%) | 42 (65.6%) | 22 (34.4%) | ||
ASA | 0.48 | 0.82 | ||||
2 | 62 (93.9%) | 4 (6.1%) | 9 (75%) | 3 (25%) | ||
3 | 480 (90.4%) | 51 (9.6%) | 75 65.8%) | 39 (34.2%) | ||
4 | 33 (86.8%) | 5 (13.2%) | 6 (66.7%) | 3 (33.3%) | ||
Stage | 0.01 | 0.92 | ||||
1 | 328 (93.4%) | 23 (6.6%) | 32 (65.3%) | 17 (34.7%) | ||
2 | 115 (87.8%) | 16 (12.2%) | 25 (65.8%) | 13 (34.2%) | ||
3 | 131 (86.2%) | 21 (13.8%) | 33 (68.8%) | 15 (31.3%) | ||
Hb g/dL, (SD) | 13.43 (1.42) | 12.08 (1.58) | < 0.0001 | 12.4 (1.3) | 12.3 (1.4) | 0.73 |